Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Hepatitis Health Center

Font Size

Hepatitis C: Progress Toward Vaccine?

Antibodies That Target the Hepatitis C Virus May Spur Creation of a Hepatitis C Vaccine
WebMD Health News

Dec. 6, 2007 -- Scientists have discovered antibodies that target the hepatitis C virus (HCV). The findings may lead to a preventive hepatitis C vaccine.

The hepatitis C virus can cause liver damage and can be deadly.

There is no hepatitis C vaccine. That's partly because "extreme variability" in HCV makes the virus a difficult target, write Mansun Law, PhD, and colleagues.

Law works in the immunology department at the Scripps Research Institute in La Jolla, Calif.

Law's team found antibodies that neutralize various forms of the hepatitis C virus. They tested those antibodies against the HCV virus in mice.

The researchers injected the antibodies into some mice. For comparison, other mice didn't get the antibodies.

After that, all of the mice were exposed to HCV. Six days later, the HCV virus was gone from the mice that had received the antibodies -- but the hepatitis C virus lingered in the other mice.

The antibodies' effects against HCV faded with time, and high doses of the antibodies were needed to curb HCV.

More work is needed, but the results are "favorable" for the prospects of developing a hepatitis C vaccine, write Law and colleagues.

Their findings appear in today's advance online edition of Nature Medicine.

Today on WebMD

Hepatitus C virus
Types, symptoms and treatments.
liver illustration
Myths and facts about this essential organ.
woman eating apple
What you need to know.
doctor and patient
What causes it?
Hepatitis C Treatment
Syringes and graph illustration
liver illustration
passport, pills and vaccine
Scientist looking in microscope
Fatty Liver Disease
Digestive Diseases Liver Transplantation
Picture Of The Liver
Image Collection